Characterisation and epitope mapping of neutralising monoclonal antibodies to A24 Cruzeiro strain of FMDV

Veterinary Microbiology

Volumn 149, Issue 1-2, 2011, Pages 242-247

  Mahapatra, M ^a   Seki, C ^b   Upadhyaya, S ^a   Barnett, P V ^a   La Torre, J ^b   Paton, D J ^a  

^a INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^b Universidad Nacional de Río Cuarto Consejo Nacional de Investigaciones Científicas y Técnicas   (Argentina)

Author keywords

Epitopes; FMD virus; Monoclonal antibodies; Neutralisation escape mutants

Indexed keywords

GLYCINE; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; STRUCTURAL PROTEIN; TRYPTOPHAN; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; FOOT AND MOUTH DISEASE VIRUS; NONHUMAN; SEROTYPE; VIRAL GENETICS; VIRUS CAPSID; VIRUS MUTANT; VIRUS STRAIN;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CAPSID PROTEINS; EPITOPE MAPPING; EPITOPES; FOOT-AND-MOUTH DISEASE VIRUS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN STRUCTURE, QUATERNARY;

FOOT-AND-MOUTH DISEASE VIRUS; MIRIDAE;

EID: 79952101005     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2010.11.003     Document Type: Article

References (24)

1. Aktas S., Samuel A.R. Identification of antigenic epitopes on the foot and mouth disease virus isolate O-1/Manisa/Turkey/69 using monoclonal antibodies. Rev. Sci. Tech. Off. Int. Epizoot. 2000, 19:744-753.
2. Barnett P.V., Ouldridge E.J., Rowlands D.J., Brown F., Parry N.R. Neutralizing epitopes of type-o foot-and-mouth-disease virus. 1. Identification and characterization of 3 functionally independent, conformational sites. J. Gen. Virol. 1989, 70:1483-1491.
3. Baxt B., Vakharia V., Moore D.M., Franke A.J., Morgan D.O. Analysis of neutralizing antigenic sites on the surface of type-a12 foot-and-mouth-disease virus. J. Virol. 1989, 63:2143-2151.
4. Bolwell C., Clarke B.E., Parry N.R., Ouldridge E.J., Brown F., Rowlands D.J. Epitope mapping of foot-and-mouth-disease virus with neutralizing monoclonal-antibodies. J. Gen. Virol. 1989, 70:59-68.
5. Brown F., Cartwright B. Purification of radioactive foot-and-mouth disease virus. Nature 1963, 21:1168-1170.
6. Crowther J.R., Farias S., Carpenter W.C., Samuel A.R. Identification of a 5th neutralizable site on type-O foot-and-mouth-disease virus following characterization of single and quintuple monoclonal-antibody escape mutants. J. Gen. Virol. 1993, 74:1547-1553.
7. Curry S., Abughazaleh R., Blakemore W., Fry E., Jackson T., King A., Lea S., Logan D., Newman J., Stuart D. Crystallization and preliminary-X-ray analysis of 3 serotypes of foot-and-mouth-disease virus. J. Mol. Biol. 1992, 228:1263-1268.
8. Ferris N.P., Abrescia N.G.A., Stuart D.I., Jackson T., Burman A., King D.P., Paton D.J. Utility of recombinant integrin alpha v beta 6 as a capture reagent in immunoassays for the diagnosis of foot-and-mouth disease. J. Virol. Methods 2005, 127:69-79.
9. Grazioli S., Fallacara F., Brocchi E. Mapping of neutralising sites on FMD virus type Asia 1 and relationships with sites described in other serotypes. Report of Session of the EUFMD 2004, 277-287.
10. Grazioli S., Moretti M., Barbieri I., Crosatti M., Brocchi E. Use of monoclonal antibodies to identify and map new antigenic determinants involved in neutralisation on FMD viruses type SAT 1 and SAT 2. Session of the Research Group of the Standing Technical Committee of EuFMD, 2006 2006, 287-297.
11. Katpally U., Fu T.M., Freed D.C., Casimiro D.R., Smith T.J. Antibodies to the buried N terminus of rhinovirus VP4 exhibit cross-serotypic neutralization. J. Virol. 2009, 83:7040-7048.
12. Kitson J.D.A., McCahon D., Belsham G.J. Sequence-analysis of monoclonal-antibody resistant mutants of type-O foot-and-mouth-disease virus-evidence for the involvement of the 3 surface exposed capsid proteins in 4 antigenic sites. Virology 1990, 179:26-34.
13. König G., Palma E., Maradei E., Piccone M. Molecular epidemiology of foot-and-mouth disease virus types A and O isolated in Argentina during the 2000-2002 epizootic. Vet. Microbiol. 2007, 20:1-15.
14. Lea S., Hernandez J., Blakemore W., Brocchi E., Curry S., Domingo E., Fry E., Abughazaleh R., King A., Newman J., Stuart D., Mateu M.G. The structure and antigenicity of a type-c foot-and-mouth-disease virus. Structure 1994, 2:123-139.
15. Lea S., Abughazaleh R., Blakemore W., Curry S., Fry E., Jackson T., King A., Logan D., Newman J., Stuart D. Structural comparison of 2 strains of foot-and-mouth-disease virus subtype-o-1 and a laboratory antigenic variant, G67. Structure 1995, 3:571-580.
16. Lentz K.N., Smith A.D., Geisler S.C., Cox S., Buontempo P., Skelton A., DeMartino J., Rozhon E., Schwartz J., Girijavallabhan V., Oconnell J., Arnold E. Structure of poliovirus type 2 Lansing complexed with antiviral agent SCH48973: comparison of the structural and biological properties of the three poliovirus serotypes. Structure 1997, 5:961-978.
17. Li Q.H., Yafal A.G., Lee Y.M.H., Hogle J., Chow M. Poliovirus neutralization by antibodies to internal epitopes of vp4 and vp1 results from reversible exposure of these sequences at physiological temperature. J. Virol. 1994, 68:3965-3970.
18. Mahapatra M., Aggarwal N., Cox S., Statham R.J., Knowles N.J., Barnett P.V., Paton D.J. Evaluation of a monoclonal antibody-based approach for the selection of foot-and-mouth disease (FMD) vaccine strains. Vet. Microbiol. 2008, 126:40-50.
19. Mateu M.G., Martinez M.A., Capucci L., Andreu D., Giralt E., Sobrino F., Brocchi E., Domingo E. A single amino-acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth-disease virus of serotype-C. J. Gen. Virol. 1990, 71:629-637.
20. McCullough K.C., Crowther J.R., Butcher R.N. A liquid-phase elisa and its use in the identification of epitopes on foot-and-mouth-disease virus-antigens. J. Virol. Methods 1985, 11:329-338.
21. Parry N., Fox G., Rowlands D., Brown F., Fry E., Acharya R., Logan D., Stuart D. structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth-disease virus. Nature 1990, 347:569-572.
22. Roivainen M., Piirainen L., Rysa T., Narvanen A., Hovi T. An immunodominant n-terminal region of vp1 protein of poliovirion that is buried in crystal-structure can be exposed in solution. Virology 1993, 195:762-765.
23. Seki C., Robiolo B., Periolo O., Iglesias M., D'Antuono A., Maradei E., Barros V., La Torre J., Mattion N. Rapid methodology for antigenic profiling of FMDV field strains and for the control of identity, purity and viral integrity in commercial virus vaccines using monoclonal antibodies. Vet. Microbiol. 2009, 133:239-251.
24. Thomas A.A.M., Woortmeijer R.J., Barteling S.J., Meloen R.H. Evidence for more than one important, neutralizing site on foot-and-mouth-disease virus. Arch. Virol. 1988, 99:237-242.